Zhejiang BornSun Medicine Co., Ltd.
Keywords : florfenicol,tilmicosin,ivermection,oxytetracyckine, enrofloxacin, amoxicillin, tiamulin,albendazol,
Description : Zhejiang BornSun MedicineCo., Ltd. is one of “key high-tech enterprises in the Torch Program of China”, dedicated exclusively to the development, manufacturing and trading of animal health products. BornSun Medicine, established in 2008, is located in Anji - the only county in China that was granted the UN Habitat Scroll of Honor, Huzhou, Zhejiang. We have eight production lines according to GMP standard, including small and large volume injection, powder, premix, granule, disinfectant, oral liquid, herbal extracts and probiotics.
Our advantages:
1. High-level production processes
We always cooperate with the well-known international universities and research institutes, and our production processes have reached domestic advanced level in the industry.
2. Seven leading key technologies
Our key technologies include nano emulsification, solid dispersion, microcapsule technology, liposome technology, ultra-fine pulverization, inclusion process and stable crystal particle. We apply the right technology to produce drug products according their characteristics.
3. Advanced production equipments
We have introduced advanced production equipments, such as new type airflow ultramicro pulverizer, type 150 high-speed centrifugal spray tower, automatic freeze dryer, F120 fluidized dry grnulator, homogenizer, ball mill, herbal medicine extraction equipment etc, which can ensure that our products are of high quality and effectiveness.
Our honors:
National High-tech Enterprise
Enterprise Research and Development Center of Zhejiang Province
Two National Invention Patents
Agricultural Science and Technology Enterprise of Zhejiang Province
Technological Innovation-based Enterprise
Seventeen New Products of Provincial Level
National Innovation Fund Project Unit
Agricultural Leading Enterprise
Forty Trademark Certificates
Zhejiang University Practice Teaching Base
Preparing to Declare National New Veterinary Drug (Type I) |
